TAIM
HAE icon

TD Ameritrade Investment Management’s Haemonetics HAE Stock Holding History

TD Ameritrade Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17
Closed -$1K – 193
2023
Q2 		$1K Hold
17
– – ﹤0.01% 510
2023
Q1 		$1K Hold
17
– – ﹤0.01% 548
2022
Q4 		$1K Sell
17
-7
-29% -$563 ﹤0.01% 546
2022
Q3 		$2K Sell
24
-8
-25% -$574 ﹤0.01% 505
2022
Q2 		$2K Hold
32
– – ﹤0.01% 541
2022
Q1 		$2K Buy
32
+8
+33% +$435 ﹤0.01% 601
2021
Q4 		$1K Buy
+24
New +$1.46K ﹤0.01% 605

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

TD Ameritrade Investment Management's HAE Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Haemonetics (HAE) in Q3 2023, closing a stake of 17 shares — an estimated $1K sold.

TD Ameritrade Investment Management first reported a position in HAE in Q4 2021 and held it in 7 quarters. The position peaked at $2K in Q3 2022. 296 funds tracked by Wall St. Rank hold HAE as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Haemonetics position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 17 Haemonetics shares in Q3 2023, an estimated $1K.
  • TD Ameritrade Investment Management first reported a position in Haemonetics in Q4 2021 and held it in 7 quarters.
  • TD Ameritrade Investment Management's Haemonetics position peaked at $2K in Q3 2022.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.